000			01714 a2200421 4500
005			20250513132448.0
264		0	_c19980106
008			199801s 0 0 eng d
022			_a0009-7322
024	7		_a10.1161/01.cir.96.11.4044 _2doi
040			_aNLM _beng _cNLM
100	1		_aFei, L
245	0	0	_aIntrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properties. _h[electronic resource]
260			_bCirculation _cDec 1997
300			_a4044-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aArginine _xadministration & dosage
650	0	4	_aConfounding Factors, Epidemiologic
650	0	4	_aDisease Models, Animal
650	0	4	_aDogs
650	0	4	_aElectric Stimulation
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aMyocardial Contraction _xdrug effects
650	0	4	_aMyocardial Infarction _xcomplications
650	0	4	_aNitric Oxide _xphysiology
650	0	4	_aNitric Oxide Synthase _xantagonists & inhibitors
650	0	4	_aNorepinephrine _xmetabolism
650	0	4	_aPericardium
650	0	4	_aSeverity of Illness Index
650	0	4	_aTachycardia, Ventricular _xetiology
650	0	4	_aomega-N-Methylarginine _xpharmacology
700	1		_aBaron, A D
700	1		_aHenry, D P
700	1		_aZipes, D P
773	0		_tCirculation _gvol. 96 _gno. 11 _gp. 4044-9
856	4	0	_uhttps://doi.org/10.1161/01.cir.96.11.4044 _zAvailable from publisher's website
999			_c9373265 _d9373265